In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.

Published Date: 03 Jun 2024

Bentuximab vedotin has significantly less toxicity and is more effective than standard chemotherapy.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.

2.

GLP-1 receptor agonists, cancer risk and questionable significance

3.

In cases of metastatic or recurrent head and neck cancer, gene-guided immunotherapy falls short.

4.

Researchers discover that children who survive cancer have socioeconomic challenges.

5.

Early Esophageal Cancer pCR Rates Are Raised by Neoadjuvant PD-1 Blockade.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot